InnovAtlasMalaria No More
Research institution

University of South Florida (USF)

DiscoverDevelop

The University of South Florida leads REDIAL, an NIAID-funded malaria research program investigating persistent malaria transmission in Cameroon.

2
Endemic countries
1
U.S. states
3
Products and programs
About

What they do

The University of South Florida leads REDIAL, an NIAID-funded malaria research program investigating persistent malaria transmission in Cameroon.1 The program studies malaria epidemiology, parasite and mosquito biology, drug and insecticide resistance, and factors that sustain transmission to help improve malaria-control strategies.1 Additional research at USF investigates cerebral malaria pathogenesis, including the role of immunothrombosis, and identifies parasite and human biomarkers that may predict clinical outcomes, in collaboration with researchers in Malawi.1 U.S. R&D is based in Tampa, Florida, and the work spans the discovery and development stages.1

In the United States
Products and programs

In the field and in development

REDIAL2,1

Unraveling the Drivers of Persistent Malaria Transmission in Cameroon: A Systems Approach (NIAID Central Africa ICEMR; U19AI181593)

Cerebral malaria pathogenesis and parasite/host biomarker research (Kami Kim Laboratory)1
Investigation of immunothrombosis in severe malaria (Kami Kim Laboratory)1
Where they work

Partnerships in 2 endemic countries

Surveillance and genomicsResearchPolicy and advocacy
Cameroon
Africa
  • The Fobang Institutes for Innovations in Science and Technology (FINISTECH) · leads field research in malaria epidemiology and drug-resistance studies1
  • University of Yaoundé I / Biotechnology Centre · leads laboratory analysis and vector studies1
  • National Malaria Control Program · key stakeholder and coordinator for the operation of research stations1
Malawi
Africa
  • Blantyre Malaria Project, Kamuzu University of Health Sciences · collaborative research on cerebral malaria pathogenesis, parasite and host biomarkers, clinical outcomes, and immunothrombosis (Kami Kim Laboratory; key collaborator Dr. Karl Seydel)1
U.S. partners

Who they work with in the United States

  • NIH/NIAID2,1
    Bethesda, MD · Funder · funder — REDIAL
Sources

Where this comes from

  1. 1Confirmed by the organization
  2. 2niaid.nih.gov